PMCK Berhad
PMCK Berhad, an investment holding company, provides specialist consultant, healthcare support, and other services in Malaysia. The company offers specialist consulting services in the areas of anaesthesiology, emergency medicine, cardiology, dermatology, internal medicine, nephrology, obstetrics and gynaecology, ophthalmology, oral and maxillofacial surgery, orthodontics, orthopaedics, otorhinol… Read more
PMCK Berhad (0363) - Net Assets
Latest net assets as of October 2025: RM155.06 Million MYR
Based on the latest financial reports, PMCK Berhad (0363) has net assets worth RM155.06 Million MYR as of October 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (RM196.08 Million) and total liabilities (RM41.02 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | RM155.06 Million |
| % of Total Assets | 79.08% |
| Annual Growth Rate | 1.19% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 2.77 |
PMCK Berhad - Net Assets Trend (2022–2024)
This chart illustrates how PMCK Berhad's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for PMCK Berhad (2022–2024)
The table below shows the annual net assets of PMCK Berhad from 2022 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-04-30 | RM84.33 Million | +4.00% |
| 2023-04-30 | RM81.09 Million | -1.54% |
| 2022-04-30 | RM82.36 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to PMCK Berhad's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2.4% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (April 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | RM75.95 Million | 90.28% |
| Other Components | RM8.18 Million | 9.72% |
| Total Equity | RM84.13 Million | 100.00% |
PMCK Berhad Competitors by Market Cap
The table below lists competitors of PMCK Berhad ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
AMBER ENERGY
MU:9AE
|
$422.32 |
|
China Food and Beverage Company
PINK:CHIF
|
$422.69 |
|
Al Arafa Investment And Consulting in EGP
EGX:AIVCB
|
$423.67 |
|
HITECH + DEVELOPMENT WIR.
F:858
|
$423.93 |
|
West River Berhad
KLSE:0353
|
$419.82 |
|
KENYA AIRWAYS LTD
USE:KA
|
$418.50 |
|
Strategic Equity Capital Closed Fund
LSE:SEC
|
$417.81 |
|
Solar Integrated Roofing Corp
PINK:SIRC
|
$417.26 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in PMCK Berhad's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 81,087,000 to 84,132,000, a change of 3,045,000 (3.8%).
- Net income of 15,045,000 contributed positively to equity growth.
- Dividend payments of 12,000,000 reduced retained earnings.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | RM15.04 Million | +17.88% |
| Dividends Paid | RM12.00 Million | -14.26% |
| Total Change | RM- | 3.76% |
Book Value vs Market Value Analysis
This analysis compares PMCK Berhad's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.66x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2022-04-30 | RM0.08 | RM0.21 | x |
| 2023-04-30 | RM0.07 | RM0.21 | x |
| 2024-04-30 | RM0.08 | RM0.21 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently PMCK Berhad utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 17.88%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.42%
- • Asset Turnover: 0.95x
- • Equity Multiplier: 1.31x
- Recent ROE (17.88%) is above the historical average (15.05%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2022 | 14.02% | 11.89% | 0.90x | 1.31x | RM3.31 Million |
| 2023 | 13.23% | 10.75% | 0.93x | 1.33x | RM2.62 Million |
| 2024 | 17.88% | 14.42% | 0.95x | 1.31x | RM6.63 Million |
Industry Comparison
This section compares PMCK Berhad's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $3,601,440,097
- Average return on equity (ROE) among peers: 32.78%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| PMCK Berhad (0363) | RM155.06 Million | 14.02% | 0.26x | $421.93 |
| TMC Life Sciences Bhd (0101) | $48.97 Million | 18.72% | 0.24x | $32.96 Million |
| Optimax Holdings Sdn Bhd (0222) | $20.79 Million | 21.38% | 1.70x | $17.14 Million |
| Cengild Medical Berhad (0243) | $9.79 Million | 40.37% | 3.81x | $11.79 Million |
| DC HEALTHCARE HOLDINGS BERHAD (0283) | $4.75 Million | 39.98% | 2.55x | $5.67 Million |
| ALPHA (0303) | $54.55 Million | 97.60% | 0.76x | $70.68 Million |
| Metro Healthcare Berhad (0329) | $34.34 Million | 27.49% | 0.46x | $4.10 Million |
| IHH Healthcare Bhd (5225) | $25.90 Billion | 3.74% | 0.50x | $6.11 Billion |
| KPJ Healthcare Bhd (5878) | $2.74 Billion | 12.92% | 1.70x | $1.99 Billion |